LARP1 antibody
-
- Target See all LARP1 Antibodies
- LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This LARP1 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC)
- Cross-Reactivity
- Human, Rat
- Purification
- Affinity purification
- Immunogen
- Recombinant protein corresponding to Mouse Salivary alpha amylase
-
anti-La Ribonucleoprotein Domain Family, Member 1 (LARP1) (AA 1-1019) antibody
LARP1 Reactivity: Human WB Host: Mouse Polyclonal unconjugated
anti-La Ribonucleoprotein Domain Family, Member 1 (LARP1) (AA 107-156) antibodyLARP1 Reactivity: Human, Rabbit, Cow, Dog, Guinea Pig, Horse, Bat WB Host: Rabbit Polyclonal unconjugated
anti-La Ribonucleoprotein Domain Family, Member 1 (LARP1) (AA 36-85) antibodyLARP1 Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
anti-La Ribonucleoprotein Domain Family, Member 1 (LARP1) (N-Term) antibodyLARP1 Reactivity: Human, Rabbit WB Host: Rabbit Polyclonal unconjugated
anti-La Ribonucleoprotein Domain Family, Member 1 (LARP1) (N-Term) antibodyLARP1 Reactivity: Human, Mouse, Rabbit, Rat, Cow, Dog, Guinea Pig, Horse WB Host: Rabbit Polyclonal unconjugated
-
- Application Notes
- WB (M,R) 1:500-1:1000, IHC/IF (H,M,R) 1:700-1:1400/1:600-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
- Target
- LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))
- Alternative Name
- LARP (LARP1 Products)
- Background
- Filament-forming cytoskeletal GTPase . May play a role in cytokinesis (Potential).
- Molecular Weight
- 42 kDa
- Gene ID
- 54204
- NCBI Accession
- NP_059489
- UniProt
- P42209
- Pathways
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-
